Previous 10 | Next 10 |
2023-08-24 09:44:18 ET The Biden administration is expected to announce the first 10 drugs that will be subject to Medicare price negotiations on Tuesday before the markets open, Politico reported, citing people familiar with the plans. The move, introduced as part of last year ...
2023-08-24 02:20:26 ET Summary Bristol-Myers has a strong history of investment outperformance during equity bear markets and recessions. The company is uniquely undervalued, with a low 8x P/E and nearly 4% cash dividend yield. After a weak first half of 2023, shares may rebou...
2023-08-23 17:48:17 ET More on CVS Health CVS Health: Blue Shield Runs To Amazon, But Valuation Still Makes Sense Walgreens Vs. CVS: I Call A Tie Now Based On A Peter Lynch Evaluation CVS: In Search Of A Major Low CVS Health: Second Quarter Was Only Decent, B...
2023-08-23 10:27:29 ET Earlier this month, the Switzerland-based pharmaceutical Novartis (NYSE: NVS) shared encouraging news from two phase 3 clinical trials of its drug candidate remibrutinib for a skin condition known as chronic spontaneous urticaria (CSU). What could this lat...
2023-08-21 15:58:31 ET More on Eli Lilly Eli Lilly Q2: Dividends Don't Lie Eli Lilly: Q2 And 2023 Revised Guidance Impressive, But Key Is Wegovy Data Eli Lilly and Co ( LLY ) Q2 2023 Earnings Call Transcript Eli Lilly Remains A Buy With Strong Sales And P...
2023-08-18 08:03:01 ET More on Novartis Novartis: Q2 Beats Expectations, But Still Pricey Novartis: Strong Growth And Continued Expansion For KISQALI Novartis Buys Chinook: M&A To Drive Future Growth Novartis and Ionis in pact for new cardiovascular thera...
2023-08-17 17:06:53 ET More on BeiGene Sales Success Comes With Side Effects For Drug Maker BeiGene Heated Market For Dueling Blood Cancer Drugs Lands BeiGene In Court BeiGene Faces Patent Battle: Confronting Uncertainty In The Oncology Market BeiGene beats t...
2023-08-17 09:20:00 ET Being a buy-and-hold investor has advantages. For instance, it can be less stressful than day trading, and the combination of time and compounding is a powerful wealth generator. However, with hundreds of options, it can be a challenge to figure out which stocks to bu...
2023-08-15 20:58:15 ET Summary Surface Oncology has agreed to be acquired by Coherus BioSciences in a deal valued at $65 million. The deal will result in a share dilution of 12.5% for CHRS, leading to a 12% reduction in its stock price since the merger announcement. SURF share...
2023-08-14 05:10:00 ET Income investing can be a great strategy for people looking to match their recurring bills with recurring dividend income. The trick is diversifying across top businesses in numerous industries to build an unstoppable stream of passive income. Many leading pharm...
News, Short Squeeze, Breakout and More Instantly...
2024-07-19 04:04:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-18 16:45:16 ET Image source: The Motley Fool. Novartis Ag (NYSE: NVS) Q2 2024 Earnings Call Jul 18, 2024 , 8:00 a.m. ET Operator Continue reading For further details see: Novartis Ag (NVS) Q2 2024 Earnings Call Transcript
2024-07-18 14:15:34 ET By most standards shares of drugmaker Novartis (NYSE: NVS) should be higher following this morning's release of its second-quarter results. The drugmaker's top and bottom lines were both better than expected, and up from year-earlier comparisons. And profit gu...